The performance of companies tied to iconic drugs like Viagra presents a nuanced investment scenario . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the patent expiration in key territories has introduced significant volatility. Investors are now grappling with the effect of lower-cos